**Core Concept**
The patient's presentation of fatigue, weight loss, and left hypochondrium heaviness, along with the laboratory findings, suggests a diagnosis of chronic myeloid leukemia (CML). CML is a type of myeloproliferative neoplasm characterized by the uncontrolled proliferation of mature and immature granulocytes, leading to an elevated white blood cell count. The disease is often associated with a specific chromosomal abnormality.

**Why the Correct Answer is Right**
The patient's peripheral smear shows an increased number of immature granulocytes, including metamyelocytes, myelocytes, promyelocytes, and blasts, which is a hallmark of CML. The presence of these cells indicates a disorder of granulopoiesis, a process regulated by the WBC1 gene, also known as BCR-ABL1. This gene fusion occurs due to a reciprocal translocation between chromosomes 9 and 22, resulting in the formation of the Philadelphia chromosome (Ph+). The BCR-ABL1 fusion protein acts as a constitutively active tyrosine kinase, leading to the uncontrolled proliferation of granulocytes.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not related to the patient's presentation and laboratory findings. The presence of blasts in the peripheral smear is a characteristic feature of acute myeloid leukemia (AML), not CML.
* **Option B:** The cytogenetic abnormality associated with acute lymphoblastic leukemia (ALL) is typically a translocation involving the MLL gene, not the BCR-ABL1 fusion.
* **Option C:** The presence of blasts in the peripheral smear is not a characteristic feature of polycythemia vera, a myeloproliferative neoplasm characterized by an overproduction of red blood cells.

**Clinical Pearl / High-Yield Fact**
The Philadelphia chromosome (Ph+) is a hallmark of CML, and the presence of this chromosomal abnormality is diagnostic. The BCR-ABL1 fusion protein is a target for tyrosine kinase inhibitors, which are used as first-line treatment for CML.

**Correct Answer: C. t(9;22)**